[38]. Lim C, Tsao M S, Le L W, et al. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer[J]. Annals of Oncology, 2015, 26(7): 1415-1421. [39]. Tischer B, Kim E S, Peters M J, et al. P3.02b-023 Physician Patterns of Care...
[38]. Lim C, Tsao M S, Le L W, et al. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer[J]. Annals of Oncology, 2015, 26(7): 1415-1421. [39]. Tischer B, Kim E S, Peters M J, et al. P3.02b-023 Physician Patterns of Care...
Cancer Immunol Res. 2016 November ; 4(11): 959–967. 2. Yarchoan M, Hopkins A, Jaffee EM.N Engl J Med. 2017 Dec 21;377(25):2500-2501. 3. Zachary R. Chalmers, et al. Genome Medicine 2017 肿瘤突变负荷(TMB)检测信息由北京阅微基因技术有限公司为您提供,如您想了解更多关于肿瘤突变负荷...
肺癌的发病率和死亡率居全球首位,除化疗、放疗和靶向治疗外,免疫治疗也成为其不容忽视的治疗策略。美国食品药品监督管理局(FDA)相继批准免疫检查点抑制剂作为晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)二线治疗和部分患者一线治疗的标准方案。美国国家综合癌症网(NCCN)也推荐免疫检查点抑制剂用于复发小细胞...
(RWS)项目的组织和实施经验,按照项目工作组专家制订的原则和标准来完成项目中的数据分析与相关评估工作;同时,志诺维思将运用其独有的多模态人工智能技术体系,在抗癌登月上搭建可复用的评估体系,包括:肿瘤基因检测分析评估平台(Cancer Genome Testing Analysis:CGTA)和多中心科研协作及表型组数据分析平台(Intelligent ...
[1].Gross L. Intradermal Immunization of C3H Mice against a Sarcoma That Originated in an Animal of the Same Line[J]. Cancer Research, 1943, 3(5): 326-333. [2].Babbitt B P, Allen P M, Matsueda G R, et al. Binding of immunogenic peptides to Ia histocompatibility molecules.[J]....
(RWS)项目的组织和实施经验,按照项目工作组专家制订的原则和标准来完成项目中的数据分析与相关评估工作;同时,志诺维思将运用其独有的多模态人工智能技术体系,在抗癌登月上搭建可复用的评估体系,包括:肿瘤基因检测分析评估平台(Cancer Genome Testing Analysis:CGTA)和多中心科研协...
而志诺维思运用了其独有的多模态人工智能技术体系，在抗癌登月上搭建可复用的评估体系，包括：肿瘤基因检测分析评估平台（Cancer Genome Testing Analysis：CGTA）和多中心科研协作及表型组数据分析平台（Intelligent Phenome Cloud: IPC），如下图。体系搭建完成后，CGTA将持续为TMB检测（或大Panel）产品提供可复用的标准...
[14] Fabrizio DA, George TJ Jr, Dunne RF, et al. Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition. J Gastrointest Oncol. 2018;9(4):610-617...
Luchini, C., et al., ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol, 2019. ...